Franz B Humer Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Franz B Humer.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Franz B Humer. Franz B Humer is Director in CITIGROUP INC ($C) and Director in Kite Pharma, Inc. ($KITE) and Director in Allogene Therapeutics, Inc. ($ALLO).
Latest Insider Trading Transactions of Franz B Humer
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 24 2019 | ALLO | Allogene Therapeut ... | Humer Franz B | Director | Grant | A | 0.00 | 16,377 | 0 | 121,247 | 104.9 K to 121.2 K (+15.62 %) |
| Apr 02 2019 | C | CITIGROUP INC | Humer Franz B | Director | Grant | A | 63.05 | 15 | 946 | 2,669 | 2.7 K to 2.7 K (+0.57 %) |
| Apr 02 2019 | C | CITIGROUP INC | Humer Franz B | Director | Grant | A | 63.05 | 151 | 9,521 | 21,304 | 21.2 K to 21.3 K (+0.71 %) |
| Feb 15 2019 | C | CITIGROUP INC | Humer Franz B | Director | Grant | A | 0.00 | 601 | 0 | 2,654 | 2.1 K to 2.7 K (+29.27 %) |
| Jan 04 2019 | C | CITIGROUP INC | Humer Franz B | Director | Grant | A | 58.01 | 36 | 2,089 | 4,693 | 4.7 K to 4.7 K (+0.77 %) |
| Jan 04 2019 | C | CITIGROUP INC | Humer Franz B | Director | Grant | A | 58.01 | 143 | 8,296 | 18,513 | 18.4 K to 18.5 K (+0.78 %) |
| Oct 17 2018 | ALLO | Allogene Therapeut ... | Humer Franz B | Director | Option Exercise | C | 0.00 | 14,261 | 0 | 0 | |
| Oct 17 2018 | ALLO | Allogene Therapeut ... | Humer Franz B | Director | Buy | C | 0.00 | 74,870 | 0 | 104,870 | 30 K to 104.9 K (+249.57 %) |
| Oct 17 2018 | ALLO | Allogene Therapeut ... | Humer Franz B | Director | Buy | P | 18.00 | 30,000 | 540,000 | 30,000 | 0 to 30 K |
| Oct 03 2018 | C | CITIGROUP INC | Humer Franz B | Director | Grant | A | 70.35 | 30 | 2,110 | 4,657 | 4.6 K to 4.7 K (+0.65 %) |
| Oct 03 2018 | C | CITIGROUP INC | Humer Franz B | Director | Grant | A | 70.35 | 117 | 8,230 | 18,370 | 18.3 K to 18.4 K (+0.64 %) |
| Jul 02 2018 | C | CITIGROUP INC | Humer Franz B | Director | Grant | A | 67.57 | 22 | 1,487 | 4,627 | 4.6 K to 4.6 K (+0.48 %) |
| Jul 02 2018 | C | CITIGROUP INC | Humer Franz B | Director | Grant | A | 67.57 | 86 | 5,811 | 18,253 | 18.2 K to 18.3 K (+0.47 %) |
| Feb 16 2018 | C | CITIGROUP INC | Humer Franz B | Director | Grant | A | 0.00 | 2,015 | 0 | 4,594 | 2.6 K to 4.6 K (+78.13 %) |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Humer Franz B | Director | Option Exercise | D | 91.21 | 8,810 | 803,560 | 0 | |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Humer Franz B | Director | Option Exercise | D | 50.87 | 7,000 | 356,090 | 0 | |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Humer Franz B | Director | Option Exercise | D | 56.12 | 20,000 | 1,122,400 | 0 | |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Humer Franz B | Director | Sell | D | 0.00 | 1,807 | 0 | 0 | 1.8 K to 0 (-100.00 %) |
| Oct 05 2017 | KITE | Kite Pharma, Inc. | Humer Franz B | Director | Sell | U | 180.00 | 4,624 | 832,320 | 1,807 | 6.4 K to 1.8 K (-71.90 %) |
| Oct 03 2017 | C | CITIGROUP INC | Humer Franz B | Director | Grant | A | 67.95 | 31 | 2,106 | 6,686 | 6.7 K to 6.7 K (+0.47 %) |
| Oct 03 2017 | C | CITIGROUP INC | Humer Franz B | Director | Grant | A | 67.95 | 65 | 4,416 | 13,895 | 13.8 K to 13.9 K (+0.47 %) |
| Jul 05 2017 | C | CITIGROUP INC | Humer Franz B | Director | Grant | A | 62.77 | 17 | 1,067 | 6,655 | 6.6 K to 6.7 K (+0.26 %) |
| Jul 05 2017 | C | CITIGROUP INC | Humer Franz B | Director | Grant | A | 62.77 | 35 | 2,197 | 13,829 | 13.8 K to 13.8 K (+0.25 %) |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | Humer Franz B | Director | Option Exercise | A | 91.21 | 8,810 | 803,560 | 8,810 | |
| Jun 22 2017 | KITE | Kite Pharma, Inc. | Humer Franz B | Director | Grant | A | 0.00 | 2,410 | 0 | 6,431 | 4 K to 6.4 K (+59.94 %) |
| Feb 17 2017 | C | CITIGROUP INC | Humer Franz B | Director | Grant | A | 0.00 | 2,550 | 0 | 6,627 | 4.1 K to 6.6 K (+62.55 %) |
| Jan 05 2017 | C | CITIGROUP INC | Humer Franz B | Director | Grant | A | 58.65 | 29 | 1,701 | 10,759 | 10.7 K to 10.8 K (+0.27 %) |
| Jan 05 2017 | C | CITIGROUP INC | Humer Franz B | Director | Grant | A | 58.65 | 19 | 1,114 | 7,077 | 7.1 K to 7.1 K (+0.27 %) |
| Oct 04 2016 | C | CITIGROUP INC | Humer Franz B | Director | Grant | A | 47.31 | 36 | 1,703 | 10,729 | 10.7 K to 10.7 K (+0.34 %) |
| Oct 04 2016 | C | CITIGROUP INC | Humer Franz B | Director | Grant | A | 47.31 | 24 | 1,136 | 7,058 | 7 K to 7.1 K (+0.34 %) |
| Jul 06 2016 | C | CITIGROUP INC | Humer Franz B | Director | Grant | A | 45.02 | 12 | 540 | 10,693 | 10.7 K to 10.7 K (+0.11 %) |
| Jul 06 2016 | C | CITIGROUP INC | Humer Franz B | Director | Grant | A | 45.02 | 8 | 360 | 7,034 | 7 K to 7 K (+0.11 %) |
| Jun 03 2016 | KITE | Kite Pharma, Inc. | Humer Franz B | Director | Option Exercise | A | 50.87 | 7,000 | 356,090 | 7,000 | |
| Jun 03 2016 | KITE | Kite Pharma, Inc. | Humer Franz B | Director | Grant | A | 0.00 | 1,950 | 0 | 4,021 | 2.1 K to 4 K (+94.16 %) |
| Apr 05 2016 | C | CITIGROUP INC | Humer Franz B | Director | Grant | A | 42.10 | 13 | 547 | 10,681 | 10.7 K to 10.7 K (+0.12 %) |
| Apr 05 2016 | C | CITIGROUP INC | Humer Franz B | Director | Grant | A | 42.10 | 4 | 168 | 7,027 | 7 K to 7 K (+0.06 %) |
| Mar 24 2016 | KITE | Kite Pharma, Inc. | Humer Franz B | Director | Grant | A | 0.00 | 2,071 | 0 | 2,071 | 0 to 2.1 K |
| Feb 18 2016 | C | CITIGROUP INC | Humer Franz B | Director | Grant | A | 0.00 | 4,049 | 0 | 7,023 | 3 K to 7 K (+136.15 %) |
| Jan 05 2016 | C | CITIGROUP INC | Humer Franz B | Director | Grant | A | 53.31 | 7 | 373 | 7,637 | 7.6 K to 7.6 K (+0.09 %) |
| Jan 05 2016 | C | CITIGROUP INC | Humer Franz B | Director | Grant | A | 53.31 | 6 | 320 | 6,006 | 6 K to 6 K (+0.10 %) |
| Oct 05 2015 | C | CITIGROUP INC | Humer Franz B | Director | Grant | A | 51.28 | 7 | 359 | 7,630 | 7.6 K to 7.6 K (+0.09 %) |
| Oct 05 2015 | C | CITIGROUP INC | Humer Franz B | Director | Grant | A | 51.28 | 6 | 308 | 6,000 | 6 K to 6 K (+0.10 %) |
| Sep 17 2015 | KITE | Kite Pharma, Inc. | Humer Franz B | Director | Option Exercise | A | 56.12 | 20,000 | 1,122,400 | 20,000 | |
| Jul 06 2015 | C | CITIGROUP INC | Humer Franz B | Director | Grant | A | 55.94 | 5 | 280 | 5,995 | 6 K to 6 K (+0.08 %) |
| Jul 06 2015 | C | CITIGROUP INC | Humer Franz B | Director | Grant | A | 55.94 | 7 | 392 | 7,622 | 7.6 K to 7.6 K (+0.09 %) |
| Apr 03 2015 | C | CITIGROUP INC | Humer Franz B | Director | Grant | A | 53.16 | 1 | 53 | 5,989 | 6 K to 6 K (+0.02 %) |
| Apr 03 2015 | C | CITIGROUP INC | Humer Franz B | Director | Grant | A | 53.16 | 1 | 53 | 7,615 | 7.6 K to 7.6 K (+0.01 %) |
| Oct 03 2012 | C | CITIGROUP INC | Humer Franz B | Director | Grant | A | 32.35 | 1 | 32 | 4,187 | 4.2 K to 4.2 K (+0.02 %) |
| Jul 03 2012 | C | CITIGROUP INC | Humer Franz B | Director | Grant | A | 0.00 | 4,186 | 0 | 4,186 | 0 to 4.2 K |
Page: 1